Explore the words cloud of the ESA -ITN project. It provides you a very rough idea of what is the project "ESA -ITN" about.
The following table provides information about the project.
AMC MEDICAL RESEARCH BV
|Coordinator Country||Netherlands [NL]|
|Total cost||3˙895˙551 €|
|EC max contribution||3˙895˙551 € (100%)|
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
|Duration (year-month-day)||from 2016-03-01 to 2020-02-29|
Take a look of project's partnership.
|1||AMC MEDICAL RESEARCH BV||NL (AMSTERDAM ZUIDOOST)||coordinator||766˙122.00|
|2||UNIVERSITY COLLEGE LONDON||UK (LONDON)||participant||546˙575.00|
|3||CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS||CH (LAUSANNE)||participant||530˙453.00|
|4||BIOMERIEUX SA||FR (Marcy l'Etoile)||participant||525˙751.00|
|5||INSTITUT EUROPEEN D ADMINISTRATION DES AFFAIRES||FR (FONTAINEBLEAU CEDEX)||participant||525˙751.00|
|6||HUMANITAS MIRASOLE SPA||IT (ROZZANO (MI))||participant||516˙122.00|
|7||ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON||EL (ATHINA)||participant||484˙773.00|
|8||ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM||NL (AMSTERDAM)||participant||0.00|
ESA-ITN will break through the state of the art in sepsis diagnostics and will train 15 early-stage researchers (ESRs) to determine the clinical potency of a variety of new complementary sepsis biomarkers. These cover the full range of the antiinflammatory response in sepsis, at genetic, molecular and cellular level. Rapid and practical biomarker diagnostics for sepsis will be developed by building on some of the world's most innovative diagnostic platforms. In addition, a whole new clinical research model that incorporates use of biomarker diagnostics will be designed and tested.
All 15 interlinked ESR projects have an interdisciplinary component (intersection of sepsis research, product development, economics and medical practice) and international (representing 10 countries) and industry collaborations (incorporating 3 diagnostics firms, 1 bioinformatics company and a business school). Interactions within the network are strengthened by meaningful secondments, which take place at private beneficiary or partner institutes.
The training programme covers: 1. Specialist training in an international, interdisciplinary and intersectorial sepsis-orientated research project; 2. Advanced technology training in pathogenesis, biomarker discovery, diagnostics, trial design and innovation management; 3. Professional training in transferable skills, including the special ESA-ITN mini-MBA.
The setup of ESA-ITN is unique as it reflects the entire innovation value chain for sepsis biomarker diagnostics. ESA-ITN is composed of leading institutes in sepsis research and a selection of Europe's top biomarker diagnostics companies. Links to various global networks and shared research infrastructures in the field of sepsis further leverage the proposition of ESA-ITN.
|Validation of the primers and setup the Fluidigm technology for analysing MDSC||Documents, reports||2020-02-25 17:07:51|
|First online version of network public multi modality website||Websites, patent fillings, videos etc.||2020-02-25 17:07:50|
|Technology set up for the of DNA methylation probes of isolated cell fractions which can be used as prognostic markers in sepsis patients||Documents, reports||2020-02-25 17:07:51|
|Validation of DNA methylation probes of isolated cell fractions||Documents, reports||2020-02-25 17:07:51|
|Validation of the array used for whole blood leukocyte DNA analyses||Documents, reports||2020-02-25 17:07:50|
|Report of studies with PTX3, TIR8 and IRAK-M targeted mice in murine models of sepsis||Documents, reports||2020-02-25 17:07:51|
|Signed PCDPs||Documents, reports||2020-02-25 17:07:52|
|Further caracterisation of MDSC subpopulations||Documents, reports||2020-02-25 17:07:51|
Take a look to the deliverables list in detail: detailed list of ESA -ITN deliverables.
|year||authors and title||journal||last update|
Aspasia Liassidou, Georgios Renieris, Dionysiaâ€Irene Droggiti, Theologia Gkavogianni, Christakis Liassides, Labros Sabracos, Evangelos J. Giamarellosâ€Bourboulis, Charalampos S. Siristatidis
Association of modulation of proâ€inflammatory responses by dectinâ€2 with preterm delivery: An experimental model
published pages: , ISSN: 1046-7408, DOI: 10.1111/aji.13216
|American Journal of Reproductive Immunology 83/3||2020-04-01|
Amira A Bhalodi, Tjitske S R van Engelen, Harjeet S Virk, W Joost Wiersinga
Impact of antimicrobial therapy on the gut microbiome
published pages: i6-i15, ISSN: 0305-7453, DOI: 10.1093/jac/dky530
|Journal of Antimicrobial Chemotherapy 74/Supplement_1||2020-04-01|
Eleonora Ciarlo, Tytti Heinonen, Charlotte ThÃ©roude, Fatemeh Asgari, Didier Le Roy, Mihai G Netea, Thierry Roger
Trained immunity confers broad-spectrum protection against bacterial infections
published pages: , ISSN: 0022-1899, DOI: 10.1093/infdis/jiz692
|The Journal of Infectious Diseases||2020-02-25|
W. Joost Wiersinga, Harjeet S. Virk, Alfredo G. Torres, Bart J. Currie, Sharon J. Peacock, David A. B. Dance, Direk Limmathurotsakul
published pages: 17107, ISSN: 2056-676X, DOI: 10.1038/nrdp.2017.107
|Nature Reviews Disease Primers 4||2020-02-25|
Nora Suzanne Wolff, Floor Hugenholtz, Willem Joost Wiersinga
The emerging role of the microbiota in the ICU
published pages: , ISSN: 1364-8535, DOI: 10.1186/s13054-018-1999-8
|Critical Care 22/1||2020-02-25|
Eleonora Ciarlo, Tytti Heinonen, Charlotte ThÃ©roude, Jacobus Herderschee, Matteo Mombelli, JÃ©rÃ´me Lugrin, Marc PfefferlÃ©, Beatrice Tyrrell, Sarah Lensch, Hans Acha-Orbea, Didier Le Roy, Johan Auwerx, Thierry Roger
Sirtuin 2 Deficiency Increases Bacterial Phagocytosis by Macrophages and Protects from Chronic Staphylococcal Infection
published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2017.01037
|Frontiers in Immunology 8||2020-02-25|
Eleni Karakike, Evangelos J. Giamarellos-Bourboulis
Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis
published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2019.00055
|Frontiers in Immunology 10||2020-02-25|
Irene T. Schrijver, Charlotte ThÃ©roude, Thierry Roger
Myeloid-Derived Suppressor Cells in Sepsis
published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2019.00327
|Frontiers in Immunology 10||2020-02-25|
ChloÃ© Albert-Vega, Dina M. Tawfik, Sophie Trouillet-Assant, Laurence Vachot, FranÃ§ois Mallet, Julien Textoris
Immune Functional Assays, From Custom to Standardized Tests for Precision Medicine
published pages: 1-9, ISSN: 1664-3224, DOI: 10.3389/fimmu.2018.02367
|Frontiers in Immunology 9||2020-02-25|
Eleni Karakike, Maria-Evangelia Adami, Malvina Lada, Theologia Gkavogianni, Ioannis M. Koutelidakis, Michael Bauer, Evangelos J. Giamarellos-Bourboulis, Iraklis Tsangaris
Late Peaks of HMGB1 and Sepsis Outcome
published pages: 1, ISSN: 1073-2322, DOI: 10.1097/shk.0000000000001265
Tytti Heinonen, Eleonora Ciarlo, Charlotte ThÃ©roude, Aimilia Pelekanou, Jacobus Herderschee, Didier Le Roy, Thierry Roger
Sirtuin 5 Deficiency Does Not Compromise Innate Immune Responses to Bacterial Infections
published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2018.02675
|Frontiers in Immunology 9||2020-02-25|
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ESA -ITN" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "ESA -ITN" are provided by the European Opendata Portal: CORDIS opendata.
Interdisciplinary connectivity: Understanding and managing complex systems using connectivity scienceRead More
Supporting the interaction of Humans and Automated vehicles: Preparing for the EnvIronment of TomorrowRead More
A training network for the design of new synthetic carbohydrate-based vaccines to combat antibiotic resistant Pseudomonas aeruginosaRead More